hotspot -WSS

hotspot

author：comprehensive 2025-09-27 12:48:53 - browse：1832

Truvian Health employee with a plate holding reagents used to measure commonly tested blood markers. Truvian

SAN DIEGO — Truvian Health, a San Diego blood diagnostics company, shared data on Tuesday showing that its benchtop instrument’s results are largely consistent with those generated by large central laboratories. But while the results lend support for the company’s vision of decentralized and widely available clinical testing, they also resurface questions about the value of an approach widely associated with the now defunct and notorious Bay Area startup Theranos.

In a multisite study, the company tested nearly 240 blood samples from healthy donors and chronic disease patients for dozens of blood-based measurements commonly ordered by doctors, from cholesterol to blood sugar to blood cell counts. Results from Truvian’s benchtop analytical instrument, with few exceptions, closely matched readings from devices used in large central labs and made by Swiss pharma giant Roche and Japanese firm Sysmex.

The findings were presented at the annual meeting of the American Association for Clinical Chemistry, recently rebranded as the Association for Diagnostics & Laboratory Medicine. It’s the first time Truvian has shared clinical data on its product, though they have not been published in a peer-reviewed journal. The company, which is planning additional validation studies, expects to submit for Food and Drug Administration approval of its device by the third quarter of 2024.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： DeepMind touts AlphaFold's new skills as protein folding AI models face off

knowledge

WSS

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Inari Medical to buy amputation prevention company LimFlow

Lung cancer screening guidelines updated for cigarette smokers

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Thousands protest mob assault of women who were paraded naked in remote Indian border state

Inari Medical to buy amputation prevention company LimFlow

Wikipedia

hotspot

knowledge

Medical leaders decry Supreme Court decision on affirmative action

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Hepatitis C has a cure — but many Americans still lack access to it

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Affirmative action in medical school literally saved lives

How to protect coverage of PrEP

Medical leaders decry Supreme Court decision on affirmative action

FDA approves first blood sugar monitor without finger pricks

Heart attack and stroke risk calculators need revising

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

explore

Gene therapy’s promise and the high cost of hope

PrEP can help anyone prevent HIV. Why do so few people take it?

Medicare must police algorithms in Medicare Advantage, Dems say

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

What Henrietta Lacks's story taught me about my role as a doctor

How a key Senate committee is planning to regulate PBMs

focus

focus

knowledge

hotspot